CTC Bio Overview
- Founded
-
1995

- Status
-
Public
- Employees
-
213

- Stock Symbol
-
060590

- Share Price
-
$6.24
- (As of Wednesday Closing)
CTC Bio General Information
Description
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.
Contact Information
Website
www.ctcbio.com
Formerly Known As
World Livestock
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Agricultural Chemicals
Stock Exchange
KRX
Primary Office
- 94 Saengmyeonggwahakgwan-gil
- Hongcheon-eup, Hongcheon-gun
- Gangwon-do
- South Korea
+82 000-0000-0000
CTC Bio Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$6.24 | $6.43 | $5.86 - $12.46 | $149M | 23.9M | 249K | -$0.11 |
CTC Bio Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 228,316 | 205,479 | 195,998 | 146,354 |
Revenue | 134,758 | 122,503 | 110,131 | 116,737 |
EBITDA | 6,024 | 1,857 | (10,539) | (2,395) |
Net Income | (2,008) | (6,389) | (16,480) | (11,782) |
Total Assets | 149,456 | 141,364 | 162,406 | 161,003 |
Total Debt | 27,434 | 30,109 | 48,342 | 55,450 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
CTC Bio Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CTC Bio Patents
CTC Bio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210039813-A1 | Capsule filling apparatus | Pending | 02-Feb-2018 | 000000000 | |
CA-3089821-A1 | Capsule filling apparatus | Pending | 02-Feb-2018 | 000000000 | |
EP-3590498-A1 | Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration | Pending | 03-Mar-2017 | 000000000 | |
EP-3590498-A4 | Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration | Pending | 03-Mar-2017 | 0000000000 | 0 |
US-20200061078-A1 | Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration | Pending | 03-Mar-2017 | A61K31/55 |